Rofecoxib [Vioxx] appears to increase the risk of myocardial infarction (MI) and sudden cardiac death (SCD) compared with celecoxib

Author:  

Publisher: Adis International

ISSN: 1173-8324

Source: Inpharma, Vol.1, Iss.1456, 2004-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract